GREENSTREET YVONNE (Chief Executive Officer) sold 6.4% of their position (6.80K shares) of ALNYLAM PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $2.23M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+13.84K
Price / share
—
Trade value
—
% of position
Common Stock
Shares
−200.00
Price / share
$323.62
Trade value
$64.72K
% of position
Common Stock
Shares
−382.00
Price / share
$324.65
Trade value
$124.02K
% of position
Common Stock
Shares
−1.10K
Price / share
$325.63
Trade value
$357.54K
% of position
Common Stock
Shares
−1.67K
Price / share
$326.81
Trade value
$545.45K
% of position
Common Stock
Shares
−1.40K
Price / share
$327.67
Trade value
$458.41K
% of position
Common Stock
Shares
−424.00
Price / share
$328.71
Trade value
$139.37K
% of position
Common Stock
Shares
−722.00
Price / share
$329.71
Trade value
$238.05K
% of position
Common Stock
Shares
−346.00
Price / share
$330.85
Trade value
$114.47K
% of position
Common Stock
Shares
−399.00
Price / share
$331.93
Trade value
$132.44K
% of position
Common Stock
Shares
−160.00
Price / share
$332.64
Trade value
$53.22K
% of position
Net shares
+7.04K
Net value
-$2.23M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/2/2026 | A · Award | +13.84K | — | — | 15.1% | 91.58K | 105.43K |
| Common Stock Direct | 3/2/2026 | S · Sale | −200.00 | $323.62 | $64.72K | 0.2% | 105.43K | 105.23K |
| Common Stock Direct | 3/2/2026 | S · Sale | −382.00 | $324.65 | $124.02K | 0.4% | 105.23K | 104.84K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.10K | $325.63 | $357.54K | 1.0% | 104.84K | 103.75K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.67K | $326.81 | $545.45K | 1.6% | 103.75K | 102.08K |
| Common Stock Direct | 3/2/2026 | S · Sale | −1.40K | $327.67 | $458.41K | 1.4% | 102.08K | 100.68K |
| Common Stock Direct | 3/2/2026 | S · Sale | −424.00 | $328.71 | $139.37K | 0.4% | 100.68K | 100.25K |
| Common Stock Direct | 3/2/2026 | S · Sale | −722.00 | $329.71 | $238.05K | 0.7% | 100.25K | 99.53K |
| Common Stock Direct | 3/2/2026 | S · Sale | −346.00 | $330.85 | $114.47K | 0.3% | 99.53K | 99.19K |
| Common Stock Direct | 3/2/2026 | S · Sale | −399.00 | $331.93 | $132.44K | 0.4% | 99.19K | 98.79K |
| Common Stock Direct | 3/2/2026 | S · Sale | −160.00 | $332.64 | $53.22K | 0.2% | 98.79K | 98.63K |
| Total | +7.04K | -$2.23M | ||||||
Stock Option (right to buy)
Common Stock
30.43K shares
Shares
+30.43K
Strike price
325.07
Held after
30.43K
Exercisable
—
Stock Price Performance Stock Unit
Common Stock
110.75K shares
Shares
+110.75K
Strike price
0.0
Held after
110.75K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock30.43K shares | 3/2/2026 | A · Award | +30.43K | 325.07 | — | 30.43K |
| Stock Price Performance Stock Unit Direct | Common Stock110.75K shares | 3/2/2026 | A · Award | +110.75K | 0.0 | — | 110.75K |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 407.00 | Indirect |
| Total | 407.00 | 407.00 indirect |